CFFP
BIIB icon

Center for Financial Planning’s Biogen BIIB Stock Holding History

Center for Financial Planning’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1
Closed – – 532
2022
Q1 		$0 Hold
1
– – ﹤0.01% 542
2021
Q4 		$0 Buy
+1
New +$257 ﹤0.01% 539
2021
Q2 		– Sell
-52
Closed -$15K – 499
2021
Q1 		$15K Hold
52
– – ﹤0.01% 333
2020
Q4 		$13K Hold
52
– – ﹤0.01% 318
2020
Q3 		$15K Hold
52
– – ﹤0.01% 282
2020
Q2 		$14K Hold
52
– – ﹤0.01% 282
2020
Q1 		$16K Hold
52
– – 0.01% 274
2019
Q4 		$15K Buy
+52
New +$14.4K ﹤0.01% 280

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Center for Financial Planning's BIIB Position: Q2 2022 in Review

Center for Financial Planning sold out of Biogen (BIIB) in Q2 2022, closing a stake of 1 share.

Center for Financial Planning first reported a position in BIIB in Q4 2019 and held it in 8 quarters. The position peaked at $16K in Q1 2020. 927 funds tracked by Wall St. Rank hold BIIB as of Q2 2022.

  • Center for Financial Planning reported no remaining Biogen position as of Q2 2022 after selling out during the quarter.
  • Center for Financial Planning sold 1 Biogen share in Q2 2022.
  • Center for Financial Planning first reported a position in Biogen in Q4 2019 and held it in 8 quarters.
  • Center for Financial Planning's Biogen position peaked at $16K in Q1 2020.
  • 927 funds tracked by Wall St. Rank held Biogen as of Q2 2022.

Based on Center for Financial Planning's 13F filing for Q2 2022, filed 12 Aug 2022.